Florian Simon

First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia

Barbara Eichhorst, Carsten Utoft Niemann, Arnon P. Kater et al. · New England Journal of Medicine · 2023 · 291 citations · Full text

Medicine, Hematology, Oncology +16

First-line venetoclax combinations versus chemoimmunotherapy in fit patients with chronic lymphocytic leukaemia (GAIA/CLL13): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial

Moritz Fürstenau, Arnon P. Kater, Sandra Robrecht et al. · The Lancet Oncology · 2024 · 77 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

COVID-19 among fit patients with CLL treated with venetoclax-based combinations

Moritz Fürstenau, Petra Langerbeins, Nisha De Silva et al. · Leukemia · 2020 · 46 citations · Full text

Life Sciences, Immunology, Oncology +2

High Expression of EpCAM and Sox2 is a Positive Prognosticator of Clinical Outcome for Head and Neck Carcinoma

Philipp Baumeister, Alessandra Hollmann, Julia Kitz et al. · Scientific Reports · 2018 · 45 citations · Full text

Medicine, Cancer Biology, Oncology +17

High karyotypic complexity is an independent prognostic factor in patients with CLL treated with venetoclax combinations

Moritz Fürstenau, Yvonne J. Thus, Sandra Robrecht et al. · Blood · 2023 · 40 citations · Full text

Medicine, Hematology, Oncology +7